Loading…
Loading…
TSNDF does not currently pay a dividend.
Capital expenditures and free cash flow cover the twelve months through Jun 30, 2026, the latest period with complete figures.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for TSNDF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses here and all seven in the Value Graph.
TapClick below to see what's inside, then upgrade to unlock for TSNDF and 80,000+ other tickers.
See exactly how TSNDF's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for TSNDF and 80,000+ other tickers.
TerrAscend Corp. operates as a cannabis enterprise, handling the cultivation, production, and distribution of various cannabis items throughout Canada and the United States. Its diverse product line encompasses vaporizable products, concentrates, topicals, dried flower, tinctures, and edible formulations. The company markets these offerings under an array of brand names such as Kind Tree Cannabis, GAGE Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, Cookies, and Lemonnade. Additionally, TerrAscend manages retail cannabis dispensaries operating under…
TerrAscend Corp. (TSND:CA) Q3 2026 Earnings Call Transcript
Q3 2026 Net Revenue of $68.2 Million, Up 4.8% Year-Over-Year Q3 2026 Gross Profit Margin of 52.3%, Up 20 Basis Points Year-Over-Year Q3 2026 Net Cash Provided from Continuing Operations of $8.8 Million, Representing 17.7% Operating Cash Flow Yield 1 Q3 2026 Free Cash Flow1 of $6.1 Million, Representing 14.0% Free Cash Flow Yield 1 17th Consecutive Quarter of Positive Cash Flow from Continuing Operations and 13th Consecutive Quarter of Positive Free Cash Flow1 TORONTO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today reported its financial results for the third quarter ended September 30, 2026. All amounts are expressed in U.S. dollars and are prepared under U.S. Generally Accepted Accounting Principles (GAAP), unless indicated otherwise.
TORONTO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. (the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that it will host a scheduled conference call to discuss the results for its third quarter ended September 30, 2026 on Thursday, November 5, 2026, at 5:00 p.m. Eastern Time.
TerrAscend (OTCMKTS:TSNDF - Get Free Report) and Milestone Scientific (NYSE: MLSS - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Institutional and Insider Ownership 5.8% of TerrAscend shares
TerrAscend's improving revenues, margins and cash flow support its recovery, while debt, competition and regulatory uncertainty remain key concerns.